ArticleJournal of gynecologic oncology2026
The situation of gynecological cancers in Thailand: incidence, histopathology, and survival outcomes from national cancer registry data.
Article in Journal of gynecologic oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveCervical, uterine, and ovarian cancers are the 3 main cancers of the female reproductive system. Analyzing data from the cancer registry database will help understand the situation and trends of these diseases.
methodsThis study utilized data from Thailand's population-based cancer registries covering 16 provinces across 5 geographic regions between 2019 and 2021. Data collection included demographic characteristics, cancer incidence, histopathology, disease stage, and survival outcomes. Incidence rates were calculated using age-standardized rates (ASRs) per 100,000 population, and 5-year survival outcomes were compared across 2 time periods (2013-2017 vs. 2018-2022).
resultsDuring 2019-2021, Thailand recorded a mean annual ASR of 132.9 for females, with cervical cancer remaining the most common gynecologic cancer. The incidence of cervical cancer decreased from 19.5 per 100,000 in 1995-2000 to 10.3 per 100,000 in 2019-2021. Uterine cancer demonstrated a rising trend, from 3.6 per 100,000 in 2004-2006 to 6.1 per 100,000 in 2019-2021, while ovarian cancer incidence remained relatively stable at 5.9 per 100,000. Five-year survival rates improved significantly across all gynecologic cancers in 2018-2022 compared with 2013-2017. The hazard ratios for overall survival by stage ranged from 0.57 to 0.81 for cervical, 0.53 to 0.82 for uterine, and 0.57 to 0.81 for ovarian cancers (all p<0.05).
conclusionThe incidence of cervical cancer in Thailand has declined over the past 2 decades, while the burdens of uterine and ovarian cancers are increasing. Five-year survival rates have significantly improved across all gynecologic cancer types.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.